Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview
Objective: We investigated the vehicle driving situation, clinical signs and symptoms of PD patients to obtain the information for safe driving. Background: PD neurologists are…Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients
Objective: To determine whether plasma ceramides, glucosylceramides, and their ratios predict cognitive decline among cognitively normal Parkinson's disease (PD) patients. Background: There are no biomarkers…Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease
Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…Is Apple Watch a new hope for patients with Parkinson’s disease?
Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…Balance in patients with newly diagnosed Parkinson´s disease – A three year follow-up of a cohort in Northern Sweden
Objective: The aim of this study was to examine balance, subjective experienced unsteadiness and self-reported falls among patients with idiopathic Parkinson´s Disease, at the very…Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)
Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of the SCOPA-AUT. Background: The scales for outcomes…Sarcopenia and dynapenia in patients with parkinsonism
Objective: The aims of the present study were to estimate prevalence of sarcopenia and dynapenia in patients with Parkinsonian syndromes and to investigate their association…How accurate is the prediction of driving ability in a Parkinson’s clinic setting?
Objective: To determine whether routine clinical assessment (motor examination, cognitive assessment and global clinical impression) accurately predicts the ability of People with Parkinson's (PwP) to…A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences
Objective: RACE-PD is a case series that aims to assess the feasibility and utility of a national program providing individuals with Parkinson's disease (PD) a…Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3beta activity
Objective: To identify disease-modifying therapy for LRRK2-G2019S parkinsonism. Background: Leucine-rich repeat kinase 2 (LRRK2) is the most common genetic cause of Parkinson's disease (PD) without…
- « Previous Page
- 1
- …
- 318
- 319
- 320
- 321
- 322
- …
- 388
- Next Page »